Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 5, 2010, Pages 1037-1043

  Gershom, E S ^a   Sutherland, M R ^b   Lollar, P ^c   Pryzdial, E L G ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contact phase; Factor VIII; Factor XII; Intrinsic pathway; Prekallikrein

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; KALLIKREIN; PREKALLIKREIN; THROMBOPLASTIN;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CELL SURFACE; CONCENTRATION (PARAMETERS); HERPES SIMPLEX VIRUS 1; HOST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; WESTERN BLOTTING; HUMAN; PHYSIOLOGY;

BLOOD COAGULATION; BLOTTING, WESTERN; HERPESVIRUS 1, HUMAN; HUMANS;

EID: 77953775812     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03789.x     Document Type: Article

References (49)

1. Roizman B, Whitley RJ, Lopez C. The human Herpesviruses 1993, New York, Raven Press
2. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vecellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thrombo Vasc Biol 2000, 20:1417-20.
3. McSorley J, Shapiro L, Brownstein MH, Hsu KC. Herpes simplex and varicella-zoster: comparative histopathology of 77 cases. Int J Dermatol 1974, 13:69-75.
4. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical restenosis. Circulation 1996, 94:922-7.
5. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restinosis after coronary atherectomy. N Eng J Med 1996, 335:624-30.
6. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W, Meyer J. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002, 33:2581-6.
7. Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Patsy BM, Tracy RP, Kuller LH, Kronmal RA. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults - The Cardiovascular Health Study. Circulation 2000, 102:2335-40.
8. Schaumburg-Lever G, Saffold OE, Orfanos CE, Lever WF. Herpes gestationis. Histology and ultrastructure. Arch Dermatol 1973, 107:888-92.
9. Phinney PR, Fligiel S, Bryson YJ, Porter DD. Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection. Arch Pathol Lab Med 1982, 106:64-7.
10. Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus induced atherosclerosis in chickens. Fed Proc 1983, 42:2476-9.
11. Span AHM, Grauls G, Bosman F, Vanboven CPA, Bruggeman CA. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 1992, 93:41-52.
12. Weck KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, Saffitz JE, Speck SH, Virgin HW. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nature (Med) 1997, 3:1346-53.
13. Hajjar DP. Viral pathogenesis of atherosclerosis: impact of molecular mimicry and viral genes. Am J Pathol 1991, 139:1195-211.
14. Visser MR, Vercellotti GM. Herpes simplex virus and athersclerosis. Eur Heart J 1993, 14(Suppl. K):39-42.
15. Sutherland MR, Raynor CM, Leenknegt H, Wright JF, Pryzdial ELG. Coagulation initiated on herpesviruses. Proc Natl Acad Sci USA 1997, 94:13510-4.
16. Livingston JR, Sutherland MR, Pryzdial ELG. Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding. Biochem J 2006, 393:529-35.
17. Sutherland MR, Friedman HM, Pryzdial ELG. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus. Thromb Haemost 2004, 92:947-55.
18. Sutherland MR, Friedman HM, Pryzdial ELG. Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1. J Thromb Haemost 2007, 5:1055-61.
19. Riddel JP, Aouizerat BE, Miaskowski C, Lillicrap DP. Theories of blood coagulation. J Pediatr Oncol Nurs 2007, 24:123-31.
20. Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, Gruber A, Gailani D. Factor XI contributes to thrombin generation in the absence of factor XII. Blood 2009, 114:452-8.
21. Gailani D, Renné T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 2007, 27:2507-13.
22. Horbett TA. Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials. Cardiovasc Pathol 1993, 2:137s-48s.
23. Renne T, Pozgajova M, Gruner S, Schuh K, Pauer HU, Burfeinf P, Gailani D, Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005, 202:271-81.
24. Lollar P, Parker ET, Curtis JE, Helgerson SL, Hoyer LW, Scott ME, Scandella D. Inhibition of human factor VIIIa by anti-A2 subunit antibodies. J Clin Invest 1994, 93:2497-504.
25. Healey JF, Lubin IM, Nakai H, Saenko EL, Hoyer LW, Scandella D, Lollar P. Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII. J Biol Chem 1995, 270:14505-9.
26. Friedman HM, Yee A, Cohen GH, Eisenberg RJ, Seidel C, Cines DB. Glycoprotein C of herpes simplex virus type 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984, 309:633-5.
27. Roizman B, Sears AE. Herpes simplex viruses and their replication. Fields Virology 1990, Fields BN, Knipe DM. In, eds, 2nd edn, New York, Raven Press, Ch.65
28. Krishnaswamy S, Nesheim ME, Pryzdial EL, Mann KG. Assembly of prothrombinase complex. Methods Enzymol 1993, 222:260-80.
29. Kimura H, Ito Y, Futamura M, Ando Y, Yabuto Y, Hoshino Y, Nishiyana Y, Moishima T. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol 2002, 67:349-53.
30. Wald A, Huang M-L, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Vener Dis Inf 2003, 188:1345-51.
31. Hojima Y, Pierce JV, Pisano JJ. Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb Res 1980, 20:149-62.
32. Guo Z, Bussard KM, Chatterjee K, Miller R, Vogler EA, Siedlecki CA. Mathematical modeling of material-induced blood plasma coagulation. Biomaterials 2006, 27:796-806.
33. Chatterjee K, Guo Z, Vogle E, Siedlecki C. Contributions of contact activation pathways of coagulation factor XII in plasma. J Biomed Mat Res A 2009, 90A:27-34.
34. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002, 277:18322-33.
35. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006, 32:32-8.
36. Vercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 1998, 9:S3-6.
37. Nicholson AC, Hajjar DP. Herpesvirus and thrombosis: activation of coagulation on the endothelium. Clin Chim Acta 1999, 286:23-9.
38. Pryzdial ELG, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994, 84:3749-57.
39. Blanchette VS, Sparling C, Turner C. Inherited bleeding disorders. Baillieres Clin Haematol 1991, 4:291-332.
40. Sorlie PD, Nieto FJ, Adam E, Shahar E, Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1 and coronary heart disease. Arch Intern Med 2000, 160:2027-32.
41. Youd P, Main J, Jackson E. Cytomegalovirus infection and thrombosis: a causative association? J Vener Dis Inf 2003, 46:141-2.
42. Witz M, Lehman J, Korzets Z. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection. Am J Hematol 2000, 64:137-9.
43. Wasif M, Greenberg B. HIV and Thrombosis: a review. AIDS Patient Care STDS 2001, 15:15-24.
44. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E-I, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002, 359:133-5.
45. Muamoto Y, Ozaki H, Takada A, Park C-H, Sunden Y, Umemura T, Kawaoka Y, Matsuda H, Kida H. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens. Microbiol Immunol 2006, 50:73-81.
46. Bodensteiner JB, Hille MR, Riggs JE. Clinical features of vascular thrombosis following varicella. Arch Pediatr Adolesc Med 1992, 146:100-2.
47. Van Hal S, Senanayake S, Hardiman R. Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. J Clin Virol 2005, 32:245-7.
48. Chen W-H. An unusual transitory increase of lupus anticoagulant in dengue virus infection complicated with cerebral ischaemia. J Infect 2006, 52:e87-91.
49. Grahame-Clarke C, Alber DG, Lucas SB, Miller R, Vallance P. Association between Kaposi's sarcoma and atherosclerosis: implications for gammaherpesviruses and vascular disease. AIDS 2001, 15:1902-4.